Biochem Pharmacol

The behavioral pharmacology of hallucinogens.

Biochem Pharmacol July 20, 2007

The behavioral pharmacology of hallucinogens.

DOI: 10.1016/j.bcp.2007.07.018 (opens in new tab) Full text (opens in new tab)

Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion.

Biochem Pharmacol March 1, 1996

Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion.

DOI: 10.1016/0006-2952(95)02397-6 (opens in new tab)

The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6).

Biochem Pharmacol March 1, 1994

The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6).

DOI: 10.1016/0006-2952(94)90386-7 (opens in new tab)

Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced decrease in striatal serotonin concentration and on the increase in striatal neurotensin and dynorphin A concentrations.

Biochem Pharmacol August 1, 1993

Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced decrease in striatal serotonin concentration and on the increase in striatal neurotensin and dynorphin A concentrations.

DOI: 10.1016/0006-2952(93)90568-h (opens in new tab)

Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors.

Biochem Pharmacol June 1, 1991

Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors.

DOI: 10.1016/0006-2952(91)90178-8 (opens in new tab)